EDGAR Filing Documents for 0001104659-23-101113

Form DRS/A - Draft Registration Statement: [Amend]

SEC Accession No. 0001104659-23-101113

Filing Date

2023-09-15

Accepted

2023-09-15 13:41:52

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS/A	3059059
2	GRAPHIC	bc_plasma-4c.jpg	GRAPHIC	119409
3	GRAPHIC	fc_fig01invea-4c.jpg	GRAPHIC	335079
4	GRAPHIC	fc_fig03dysreg-4c.jpg	GRAPHIC	250598
5	GRAPHIC	fc_fig04cellbio-4c.jpg	GRAPHIC	207072
6	GRAPHIC	fc_fig05inflama-4c.jpg	GRAPHIC	174311
7	GRAPHIC	fc_fig06mediator-4c.jpg	GRAPHIC	316571
8	GRAPHIC	fc_imidsubmet-4c.jpg	GRAPHIC	236596
9	GRAPHIC	fc_lpsatpmousemodel-4c.jpg	GRAPHIC	243641
10	GRAPHIC	fc_pipelinee-4c.jpg	GRAPHIC	211619
11	GRAPHIC	fc_triggers-4c.jpg	GRAPHIC	140382
12	GRAPHIC	lc_fig08primary-bw.jpg	GRAPHIC	63158
13	GRAPHIC	lc_fig09igascor01-bw.jpg	GRAPHIC	44083
14	GRAPHIC	lc_fig09igascor02-bw.jpg	GRAPHIC	43634
15	GRAPHIC	lc_fig12plasma-bw.jpg	GRAPHIC	205627
16	GRAPHIC	lc_fig14inva8001-bw.jpg	GRAPHIC	148895
17	GRAPHIC	lc_fig19elevated-bw.jpg	GRAPHIC	152567
18	GRAPHIC	lg_inveatherapeutics-4c.jpg	GRAPHIC	27700
19	GRAPHIC	lg_inveatherapeutics-4clr.jpg	GRAPHIC	24746
20	GRAPHIC	ph_fig18bone-4c.jpg	GRAPHIC	457550
21	GRAPHIC	ph_intactskin-4c.jpg	GRAPHIC	1078105
22	GRAPHIC	tb_adseverity-4c.jpg	GRAPHIC	64468
23	GRAPHIC	tb_assesment-4c.jpg	GRAPHIC	140494
24	GRAPHIC	tb_enzyme-4c.jpg	GRAPHIC	72895
25	GRAPHIC	tb_mean-bw.jpg	GRAPHIC	154988
26	GRAPHIC	tb_placebo-4c.jpg	GRAPHIC	111566
27	GRAPHIC	tb_report-4c.jpg	GRAPHIC	451046
28	GRAPHIC	tb_system-4c.jpg	GRAPHIC	333490
29	GRAPHIC	tb_system01-4c.jpg	GRAPHIC	309412
30	GRAPHIC	tb_system02-4c.jpg	GRAPHIC	499109
31	GRAPHIC	tbl_majortheraoeutic-4c.jpg	GRAPHIC	666364
	Complete submission text file	0001104659-23-101113.txt		12713595

Mailing Address 2614 BOSTON POST ROAD, #33A GUILFORD CT 06437

Business Address 2614 BOSTON POST ROAD, #33A GUILFORD CT 06437 203-204-6363

Invea Therapeutics, Inc (Filer) CIK: 0001906425 (see all company filings)